Intellia Therapeutics (38I.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.39
-1.27
-1.16
-1.04

Details

Expected EPS
-1.2869962553
Actual EPS
-1.2405854
Surprise EPS
0.05
Surprise Percent
+3.61%

Description

Intellia Therapeutics (38I.F) has reported earnings of -1.2405854 per share for Q4 2024.

0 Comments

Share your thoughts